Skip to content

Hawkins HWKN Restricted stock acquisition consideration

Restricted stock acquisition consideration at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$7.71M+53,067%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
HWK
HawkinsHWKN
$0
TFS Financial logo
TFS FinancialTFSL
$0
Rumble, Inc. logo
Rumble, Inc.RUM
$89.05K+85.5%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0

Other financials

Income statement

See full
Revenue$265.9M+8.4%
Gross profit$54.2M+3.8%
Operating income$23.5M-4.5%
Net income$15.5M-5.3%
EPS (diluted)$0.74-5.1%

Balance sheet

See full
Cash & equivalents$3.9M-23.3%
Total debt$261.5M+51.4%
Total equity$534.0M+16.0%
Total assets$986.3M+28.1%

Cash flow

See full
Operating cash flow$37.7M+22.3%
CapEx$19.6M+76.6%
Free cash flow$18.2M-8.1%

Valuation

See full
Market cap$3.42B+44.8%

Profitability

See full
Gross margin22.6%-0.5pp
Operating margin11.2%-1.0pp
Net margin7.5%-1.1pp
FCF margin7.9%+0.8pp

Returns & leverage

See full
Return on equity16.4%-3.1pp
Debt / equity0.5×+0.1×
Current ratio2.2×-0.2×

Where this comes from

Reported directly by Hawkins in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross.

The official record: Hawkins’s 10-Q, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hawkins's restricted stock acquisition consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hawkins's restricted stock acquisition consideration?
Hawkins (HWKN) reported restricted stock acquisition consideration of $0 in Q3 2025.
What does restricted stock acquisition consideration mean?
This represents the fair value of restricted stock awards granted to employees or directors as part of compensation packages. It reflects the company's use of equity-based incentives to align the interests of key personnel with those of shareholders.